Financial statements Active Pharma
Balance sheet data of ACTIVE PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 1 029 052,52 | 585 861,56 | 975 584,49 | 882 729,92 | 867 669,58 |
| A. Fixed assets | 47 503,13 | 31 829,78 | 22 578,55 | 19 728,25 | 16 901,94 |
| B. Current assets | 981 549,39 | 554 031,78 | 953 005,94 | 863 001,67 | 850 767,64 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 029 052,52 | 585 861,56 | 975 584,49 | 882 729,92 | 867 669,58 |
| A. Equity | 750 016,31 | 310 252,64 | 737 110,45 | 602 404,76 | 380 039,15 |
| B. Liabilities and provisions for liabilities | 279 036,21 | 275 608,92 | 238 474,04 | 280 325,16 | 487 630,43 |
| I. Long-term liabilities | 0,00 | 0,00 | 48 000,00 | 45 480,46 | 39 471,05 |
| II. Short-term liabilities | 275 197,81 | 272 403,92 | 249 474,04 | 234 472,70 | 393 659,38 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.